Lisa Fitzgerald

Lisa Fitzgerald is currently the Director of Clinical Operations at Valerio Therapeutics, where Lisa leads specialized teams to deliver high-priority projects and strategizes to shorten timelines for study start and recruitment. Prior to their current role, Lisa held positions such as Director of Clinical Operations at Checkpoint Therapeutics Inc, where Lisa managed phase 2-3 clinical trials, and Associate Director of Clinical Operations at Mallinckrodt Pharmaceuticals. With previous experience at companies like Johnson & Johnson, Novartis, and Ferring Pharmaceuticals, Lisa has a strong background in managing clinical studies and global clinical research. Lisa holds an MBA with a concentration in Management from Centenary University and a Bachelor's degree from Montclair State University.